株式会社極東書店トップ ＞ 商品一覧 ＞ Real-World Evidence in Drug Development and Evaluation.
商品詳細
Real-World Evidence in Drug Development and Evaluation.
・ISBN 978-0-367-02621-9 2021 hard GB£ 145.99
￥46,249.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
・ISBN 978-0-367-63701-9 2022 paper GB£ 53.99
￥17,103.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
電子版あり 大学・学術機関向け電子ブック（eBook）ISBN 978-0-429-39867-4
| 著者・編者 | Yang, Harry / Yu, Binbing (eds.), |
|---|---|
| シリーズ | Chapman & Hall/CRC Biostatistics Series |
| 出版社 | (Chapman & Hall/CRC, UK) |
| ページ数 | 178 pp. |
| 言語 | ENG |
| ニュース番号 | ＜M25-5252＞ |
解説
Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field.
Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions.
Features
- Provides the first book and a single source of information on RWE in drug development
- Covers a broad array of topics on outcomes- and value-based RWE assessments
- Demonstrates proper Bayesian application and causal inference for real-world data (RWD)
- Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insights
- Offers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise